Evaluation of the clinical utility of the promarkerd in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis

HIGHLIGHTS

• who: Lauren Fusfeld and collaborators from the Proteomics International, Perth, Australia, Stony Brook University Medical Center, Stony Brook, NY have published the paper: Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis, in the Journal: PLOS ONE of July/15,/2021
• what: Objective This study evaluated the impact of PromarkerD a biomarker-based blood test predicting the risk of diabetic kidney disease (DKD) and rapid renal decline. This study evaluates the impact of PromarkerD versus other type 2 diabetes_mellitus patient . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.